The Skeptical
Investing Blog

Ultragreen.AI is down c40% over the past month as its "monopoly" status has come under threat with new entrants gaining FDA approvals in the US for ICG. We think the share price reaction is overdone as both volumes and ASP erosion could be more manageable than expected. Read on for more.

Using a VIX Oct/Nov 19 put calendar to position for elevated election-related volatility into November and compression post-election

Hong Kong equities have underperformed mainland Chinese markets despite a stable political environment, recovering property market, and resilient economic backdrop. This divergence is noteworthy given the historically close linkage between Hong Kong and mainland Chinese equity markets. In this article, we examine the key factors that may be driving the growing disconnect.